Get the latest updates on U.S. startups securing Series A and B funding, featuring key deals, top investors, and emerging industries shaping the future.
All content for The Series A & B Investor Daily Brief is the property of PodcastAI and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Get the latest updates on U.S. startups securing Series A and B funding, featuring key deals, top investors, and emerging industries shaping the future.
Key Series A Rounds: Allink, Celosia, Constrafor, Roon, and Doron Therapeutics
The Series A & B Investor Daily Brief
14 minutes 24 seconds
1 year ago
Key Series A Rounds: Allink, Celosia, Constrafor, Roon, and Doron Therapeutics
Episode 5 explores a diverse array of Series A funding rounds, starting with Allink Biotherapeutics securing $42 million, providing insights into their biotherapeutic advancements. Celosia Therapeutics' Series A funding is highlighted for its focus on ALS gene therapy. The episode also features Constrafor's impressive $264 million Series A, driving innovation in the construction industry. Additionally, Roon's Series A funding is covered, emphasizing expansion in women's health information, alongside Doron Therapeutics' Series A earmarked for Phase 3 clinical studies in osteoarthritis.
The Series A & B Investor Daily Brief
Get the latest updates on U.S. startups securing Series A and B funding, featuring key deals, top investors, and emerging industries shaping the future.
